$2.37 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 95 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRput | $138,702,200 | – | 1,820,000 | +100.0% | 5.86% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $126,910,900 | – | 310,000 | +100.0% | 5.36% | – |
| AMZN | New | AMAZON COM INC | $57,789,722 | – | 559,490 | +100.0% | 2.44% | – |
| YUM | New | YUM BRANDS INC | $52,310,284 | – | 396,050 | +100.0% | 2.21% | – |
| ETNB | New | 89BIO INC | $33,666,463 | – | 2,210,536 | +100.0% | 1.42% | – |
| KRE | New | SPDR SER TRput | $29,057,250 | – | 662,500 | +100.0% | 1.23% | – |
| PINS | New | PINTEREST INCcl a | $24,749,161 | – | 907,560 | +100.0% | 1.04% | – |
| New | WARNER BROS DISCOVERY INC | $21,528,463 | – | 1,425,726 | +100.0% | 0.91% | – | |
| PYPL | New | PAYPAL HLDGS INC | $20,064,715 | – | 264,218 | +100.0% | 0.85% | – |
| COF | New | CAPITAL ONE FINL CORP | $19,962,816 | – | 207,600 | +100.0% | 0.84% | – |
| GS | New | GOLDMAN SACHS GROUP INC | $18,852,985 | – | 57,635 | +100.0% | 0.80% | – |
| WFC | New | WELLS FARGO CO NEW | $12,555,008 | – | 335,875 | +100.0% | 0.53% | – |
| MRVL | New | MARVELL TECHNOLOGY INC | $12,526,690 | – | 289,300 | +100.0% | 0.53% | – |
| MTCH | New | MATCH GROUP INC NEW | $11,394,190 | – | 296,801 | +100.0% | 0.48% | – |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $7,473,301 | – | 679,391 | +100.0% | 0.32% | – |
| SANA | New | SANA BIOTECHNOLOGY INC | $6,912,126 | – | 2,113,800 | +100.0% | 0.29% | – |
| INCY | New | INCYTE CORP | $2,717,352 | – | 37,600 | +100.0% | 0.12% | – |
| GILD | New | GILEAD SCIENCES INC | $1,883,419 | – | 22,700 | +100.0% | 0.08% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $1,372,892 | – | 15,100 | +100.0% | 0.06% | – |
| CI | New | THE CIGNA GROUP | $1,022,120 | – | 4,000 | +100.0% | 0.04% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $999,000 | – | 60,000 | +100.0% | 0.04% | – |
| PODD | New | INSULET CORP | $791,021 | – | 2,480 | +100.0% | 0.03% | – |
| A | New | AGILENT TECHNOLOGIES INC | $690,317 | – | 4,990 | +100.0% | 0.03% | – |
| DXCM | New | DEXCOM INC | $683,138 | – | 5,880 | +100.0% | 0.03% | – |
| AVTR | New | AVANTOR INC | $325,556 | – | 15,400 | +100.0% | 0.01% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $304,586 | – | 1,360 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-13 |
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.